Literature DB >> 22105212

White matter disease: A novel approach to treatment of neuromyelitis optica.

Heather Wood.   

Abstract

Entities:  

Year:  2011        PMID： 22105212     DOI： 10.1038/nrneurol.2011.188

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  3 in total

1.  Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.

Authors:  Lukmanee Tradtrantip; Hua Zhang; Samira Saadoun; Puay-Wah Phuan; Chiwah Lam; Marios C Papadopoulos; Jeffrey L Bennett; A S Verkman
Journal:  Ann Neurol       Date:  2012-01-23       Impact factor: 10.422

2.  Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.

Authors:  Hua Zhang; Jeffrey L Bennett; A S Verkman
Journal:  Ann Neurol       Date:  2011-11-08       Impact factor: 10.422

Review 3.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.